0.19Open0.19Pre Close0 Volume137 Open Interest135.00Strike Price0.00Turnover244.40%IV75.14%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.19Extrinsic Value100Contract SizeAmericanOptions Type0.0263Delta0.0029Gamma406.26Leverage Ratio-0.1154Theta0.0002Rho10.67Eff Leverage0.0052Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet